Literature DB >> 1463095

Clear cell sarcoma of soft tissues. Mayo Clinic experience with 35 cases.

D R Lucas1, A G Nascimento, F H Sim.   

Abstract

Thirty-five cases of clear cell sarcoma of soft tissues were studied to determine the clinical or morphologic features that are important in predicting prognosis. Tumors occurred most commonly in the extremities, and the majority of the patients were young women. Surgery was the elected treatment in every case. Five patients experienced local recurrences, and metastases developed in 22. Fifty-four percent of the patients died of tumor, 11% are alive with disease, and the remaining 34% are alive and well; the average survival for each group was 67 months, 113 months, and 103.5 months, respectively. This sarcoma is characterized by small clusters of polygonal to spindle cells featuring clear to slightly basophilic cytoplasm and vesicular nuclei with prominent nucleoli. The clusters are separated by delicate fibrous septa. In a deletion, clear cell sarcoma has low mitotic activity, little or no necrosis, and mild nuclear pleomorphism. Tumor size and the presence of necrosis are statistically significant predictors of prognosis. All 12 patients with tumors measuring > 5 cm died of disease or are alive with disease. Eleven of the 20 patients with tumors measuring < 5 cm are alive with no evidence of disease. Tumor necrosis was present in 10 cases; eight of these patients died of disease and one is alive with disseminated metastases.

Entities:  

Mesh:

Year:  1992        PMID: 1463095     DOI: 10.1097/00000478-199212000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  36 in total

1.  Primary clear cell sarcoma of bone.

Authors:  J H Choi; M J Gu; M J Kim; Y K Bae; W H Choi; D S Shin; K H Cho
Journal:  Skeletal Radiol       Date:  2003-09-02       Impact factor: 2.199

2.  Primary clear cell sarcoma of the sacrum: a case report.

Authors:  Weibin Zhang; Yuhui Shen; Rong Wan; YanBo Zhu
Journal:  Skeletal Radiol       Date:  2010-12-23       Impact factor: 2.199

3.  A slow-growing prepatellar mass in a 31-year-old woman.

Authors:  J L Bron; W J Mooi; R Saouti; P I J M Wuisman
Journal:  Clin Orthop Relat Res       Date:  2008-02-08       Impact factor: 4.176

4.  Radiology for the surgeon. Musculoskeletal case 38. Diagnosis: clear cell sarcoma of the foot.

Authors:  Nizar A Al-Nakshabandi; Peter L Munk
Journal:  Can J Surg       Date:  2007-02       Impact factor: 2.089

Review 5.  Clear cell sarcoma-A review.

Authors:  Rami Mossad Ibrahim; Signe Steenstrup Jensen; Jacob Juel
Journal:  J Orthop       Date:  2018-09-06

6.  Primary clear cell sarcoma of rib.

Authors:  Murat Ali Hersekli; Gurkan Ozkoc; Sema Bircan; Sercan Akpinar; Metin Ozalay; Ilhan Tuncer; Reha N Tandogan
Journal:  Skeletal Radiol       Date:  2004-12-08       Impact factor: 2.199

7.  Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.

Authors:  Cristina R Antonescu; Sylvia J Tschernyavsky; James M Woodruff; Achim A Jungbluth; Murray F Brennan; Marc Ladanyi
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

8.  Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma.

Authors:  Markus Hantschke; Thomas Mentzel; Arno Rütten; Gabriele Palmedo; Eduardo Calonje; Alexander J Lazar; Heinz Kutzner
Journal:  Am J Surg Pathol       Date:  2010-02       Impact factor: 6.394

9.  Clear cell sarcoma of the upper thoracic back muscle.

Authors:  Dae-Hyun Kim; Ki-Hwan Choi; Young-Dae Cho
Journal:  J Korean Neurosurg Soc       Date:  2009-02-28

10.  Clear cell sarcoma: a case mimicking primary cutaneous malignant melanoma.

Authors:  M Rodríguez-Martín; M Sáez-Rodríguez; B Esquivel; R Sánchez Gonzáalez; A Noda Cabrera; A Martín Herrera
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.